These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 94046)
1. Conference on Combined Modalities: Chemotherapy/Radiotherapy. Part 2. Hilton Head Island, South Carolina, November 15-18, 1978. Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1425-723. PubMed ID: 94046 [No Abstract] [Full Text] [Related]
2. Conference on combined modalities: chemotherapy/radiotherapy. Hilton Head Island, South Carolina, November 15-18, 1978. Int J Radiat Oncol Biol Phys; 1979 Aug; 5(8):1139-423. PubMed ID: 43303 [No Abstract] [Full Text] [Related]
3. C.R.O.S. conference on combined modalities chemotherapy/radiotherapy. Hilton Head Island, South Carolina, November 15--18, 1978. Carter SK Cancer Chemother Pharmacol; 1979; 2(2):139-42. PubMed ID: 43777 [No Abstract] [Full Text] [Related]
5. Current investigational drugs of interest in the Chemotherapy Program of the National Cancer Institute. Carter SK; Slavik M Natl Cancer Inst Monogr; 1977 Mar; (45):101-21. PubMed ID: 73134 [No Abstract] [Full Text] [Related]
6. Combination chemotherapy with cyclophosphamide, vincristine, methyl-CCNU, and bleomycin in advanced bronchogenic carcinoma: experience with 106 patients. Samson MK; Baker LH; Fraile RJ; Izbicki RM; Vaitkevicius VK Cancer Treat Rep; 1977; 61(1):59-64. PubMed ID: 67895 [TBL] [Abstract][Full Text] [Related]
7. The role of chemotherapy in the treatment of lung cancer. Selawry OS Semin Oncol; 1974 Sep; 1(3):259-72. PubMed ID: 4143488 [No Abstract] [Full Text] [Related]
8. [Cytostatic chemotherapy in lymphogranulomatosis]. Stacher A Med Klin; 1973 Jul; 68(30):985-8. PubMed ID: 4131695 [No Abstract] [Full Text] [Related]
9. New agents and combinations in the treatment of bronchogenic carcinoma. Bodey GP; Gottlieb JA; Livingston R; Frei E Cancer Chemother Rep 3; 1973 Mar; 4(2):227-9. PubMed ID: 4125740 [No Abstract] [Full Text] [Related]
10. Hexamethylmelamine, bleomycin, and CCNU chemotherapy for patients with squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung unresponsive to cyclophosphamide, adriamycin, methotrexate, and procarbazine. Mintz U; Bitran JD; Cooksey JA; Desser RK; DeMeester TR; Golomb HM Cancer Treat Rep; 1978 Apr; 62(4):567-9. PubMed ID: 77725 [No Abstract] [Full Text] [Related]
11. Solid tumor chemotherapy: new drugs and horizons. Yardumian H J Am Osteopath Assoc; 1974 Dec; 74(4):299-306. PubMed ID: 4140203 [No Abstract] [Full Text] [Related]
12. [Chemotherapy of tumors. 3. Chemical review of natural antineoplastic agents: antibiotics and related compounds; enzymes and hormones]. Artico M Farmaco Sci; 1974 Aug; 29(8):598-646. PubMed ID: 4136312 [No Abstract] [Full Text] [Related]
13. [Chemotherapy of inoperable cancer of the stomach]. RaevskiÄ IG Sov Med; 1974 Oct; (10):30-5. PubMed ID: 4428239 [No Abstract] [Full Text] [Related]
14. New antineoplastic drugs and their proper use. Cohen FB; Lippman AJ; Custodio MC; Decter JA Med Clin North Am; 1976 Sep; 60(5):959-70. PubMed ID: 59843 [No Abstract] [Full Text] [Related]
15. Chemotherapeutic response of epithelial tumors produced by primary implantation of a nonproducer line of murine sarcoma virus-transformed BALB 3T3 cells. Ikawa Y; Brescia T; Johnson RK; Goldin A Cancer Chemother Rep; 1973 Apr; 57(2):149-58. PubMed ID: 4126380 [No Abstract] [Full Text] [Related]
16. Biochemical aspects of drug combinations. Brockman RW Cancer Chemother Rep 2; 1974 Mar; 4(1):115-29. PubMed ID: 4135108 [No Abstract] [Full Text] [Related]
17. Cancer chemotherapy. II. Greenwald ES N Y State J Med; 1972 Nov; 72(21):2641-54. PubMed ID: 4117677 [No Abstract] [Full Text] [Related]
18. Phase II study of the effect of methyl-CCNU (NSC-95441) on bronchogenic carcinoma. Takita H; Brugarolas A; Mittelman A; Vincent R Cancer Chemother Rep 3; 1973 Mar; 4(2):257-9. PubMed ID: 4125743 [No Abstract] [Full Text] [Related]
19. Combination chemotherapy with CCNU (NSC-79037) and 5-(3, 3-bis(2-chloroethyl)-1-triazeno)-imidazole-4-carboxamide (NSC-82196). Chang H; Freireich EJ; Khaliq A; Einhorn L; Gottlieb JA Cancer Chemother Rep; 1975; 59(4):769-71. PubMed ID: 1100230 [No Abstract] [Full Text] [Related]